Return to homepagePandemic Pact

New Weapons Against Corona Virus

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Principal Investigator

    Prof Dr Stefan Knapp

  • Research Location

    Germany

  • Lead Research Institution

    Institute for Pharmaceutical Chemistry, Goethe University

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Active ingredients against the SARS-CoV-2 virus are focused on a research project at the Institute for Pharmaceutical Chemistry: In cooperation with the Institute for Medical Virology at the University Hospital, the scientists are looking for inhibitors against human proteins and a viral protein that is crucial for virus replication . They are also developing an inhibitor against a human protein that the virus uses to enter cells. The Goethe Corona Fund supports the two-part project with funds for data collection and processing, as well as for in vivo testing and screening. "I create ideas for new therapies that stop the uninhibited reproduction of the SARS-CoV-2 virus in patients."